Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

Share on Pinterest Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide ... easy to manage. Eli Lilly also states that vial forms are cheaper than ...

Patrik Jonsson is an executive vice president at Eli Lilly and president of Lilly Cardiometabolic ... Like Ozempic, the new pill is designed to mimic the glucagon-like peptide 1 hormone that ...

Patrik Jonsson is an executive vice president at Eli Lilly and president of Lilly Cardiometabolic ... Like Ozempic, the new pill is designed to mimic the glucagon-like peptide 1 hormone that our ...